CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients.

Autor: Attia HRM; Medical Research and Clinical Studies Institute, Clinical and Chemical Pathology Department, Centre of Excellence, National Research Centre, Cairo, Egypt., Kamel MM; Clinical Pathology Department, National Cancer Institute, Cairo University, Kasr Al-Aini Street, From El-Khalig Square, Cairo, 11796, Egypt. mahmoud.kamel@nci.cu.edu.eg., Ayoub DF; Medical Research and Clinical Studies Institute, Clinical and Chemical Pathology Department, Centre of Excellence, National Research Centre, Cairo, Egypt., Abd El-Aziz SH; Medical Research and Clinical Studies Institute, Clinical and Chemical Pathology Department, Centre of Excellence, National Research Centre, Cairo, Egypt., Abdel Wahed MM; Medical Research and Clinical Studies Institute, Clinical and Chemical Pathology Department, Centre of Excellence, National Research Centre, Cairo, Egypt., El-Fattah SNA; Medical Research and Clinical Studies Institute, Clinical and Chemical Pathology Department, Centre of Excellence, National Research Centre, Cairo, Egypt., Ablel-Monem MA; Medical Research and Clinical Studies Institute, Medical Biochemistry Department, Centre of Excellence, National Research Centre, Cairo, Egypt., Rabah TM; Medical Research and Clinical Studies Institute, Community Medicine Research Department, National Research Centre, Cairo, Egypt., Helal A; Baheya Centre of Early Detection and Treatment of Breast Cancer, Giza, Egypt.; Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt., Ibrahim MH; Medical Research and Clinical Studies Institute, Clinical and Chemical Pathology Department, Centre of Excellence, National Research Centre, Cairo, Egypt.

Publikováno v: Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7922. Date of Electronic Publication: 2024 Apr 04.